| |
| |
|
| Insider
Information: |
Baskett Forest |
| Relationship: |
10% Owner |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
61 |
|
| Direct
Shares |
11,602,787 |
|
|
Indirect Shares
|
327,862,954 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$948,470,417 |
|
|
| Total
Shares |
339,465,741 |
|
|
| Total
Value |
$948,470,417 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
15
|
|
Stock
price went up :
|
3
|
7
|
| Stock
price went down : |
2
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
1.5
|
| Percentage
Gain/Loss : |
 38.2%
|
192.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atheros Communications Inc |
ATHR |
Director |
|
0 |
2006-10-31 |
11,039 |
Premium* |
|
|
Innerworkings Inc |
INWK |
10% Owner |
|
0 |
2012-03-28 |
15,000 |
Premium* |
|
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
|
0 |
2011-03-10 |
0 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
|
0 |
2012-02-28 |
195 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2010-06-30 |
0 |
2014-08-29 |
4,659,333 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
10% Owner |
|
0 |
2013-09-13 |
41,260 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2013-06-03 |
2,483 |
Premium* |
|
|
Audience Inc |
ADNC |
Director |
2012-05-15 |
0 |
2013-12-03 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
10% Owner |
2012-07-03 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2015-05-07 |
0 |
Premium* |
|
|
Millennial Media Inc |
MM |
10% Owner |
2012-10-29 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-09 |
0 |
2013-04-10 |
10,396 |
Premium* |
|
|
Tableau Software Inc |
DATA |
Director |
2016-12-05 |
0 |
2016-11-11 |
0 |
Premium* |
|
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,260,851 |
Premium* |
|
|
Care.com Inc |
CRCM |
10% Owner |
2014-01-29 |
0 |
2017-11-06 |
2,302 |
Premium* |
|
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
10% Owner |
2014-12-23 |
0 |
2021-12-15 |
2,258,850 |
Premium* |
|
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
10% Owner |
2015-06-15 |
0 |
2015-11-11 |
212,650 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2022-10-19 |
3,220 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2017-07-03 |
0 |
2020-09-14 |
1,602 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
|
Appian Corp |
APPN |
10% Owner |
2017-11-20 |
0 |
2018-02-13 |
2,031 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
|
Elastic N.v. |
ESTC |
10% Owner |
2018-10-10 |
0 |
2018-10-10 |
2,197,503 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
10,421,428 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
1,548 |
Premium* |
|
|
Cloudflare, Inc. |
NET |
10% Owner |
2020-05-19 |
0 |
2020-11-11 |
204,970 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
0 |
2021-05-24 |
1,629 |
Premium* |
|
|
Sprout Social, Inc. |
SPT |
10% Owner |
2020-11-13 |
0 |
2020-11-13 |
33,234 |
Premium* |
|
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
7,333 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
|
Coursera, Inc. |
COUR |
10% Owner |
|
0 |
2023-02-15 |
2,306,303 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Robinhood Markets, Inc. |
HOOD |
Director |
2021-08-02 |
0 |
2022-05-02 |
36,688 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-06-21 |
6,745,262 |
2022-12-22 |
0 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
10% Owner |
2022-10-25 |
4,857,525 |
2022-10-25 |
0 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
0 |
2022-11-16 |
9,525 |
Premium* |
|
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
10% Owner |
2024-01-29 |
0 |
2024-01-29 |
11,300 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– – • |
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
10% Owner |
– – • |
2024-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
272,250 |
11,300 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
10% Owner |
– – • |
2024-01-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,110,950) |
0 |
0 |
- |
|
| KRRO |
Korro Bio |
10% Owner |
– – • |
2023-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,072,936 |
|
- |
|
| SVRA |
Savara Inc |
10% Owner |
– – • |
2023-07-17 |
4 |
B |
$3.00 |
$999,999 |
I/I |
333,333 |
24,471,264 |
1.5 |
% |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
31,548 |
1,548 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
| COUR |
Coursera, Inc. |
10% Owner |
– – • |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
I/I |
960,882 |
100,420 |
0 |
- |
|
| COUR |
Coursera, Inc. |
10% Owner |
– – • |
2023-02-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,921,000) |
0 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2022-12-22 |
4 |
S |
$31.45 |
$51,207 |
I/I |
(1,628) |
0 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
31,628 |
1,628 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,294,207) |
0 |
0 |
- |
|
| IONQ |
Ionq Ord Shs |
10% Owner |
– – • |
2022-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(11,867,242) |
0 |
0 |
- |
|
| IONQ |
Ionq Ord Shs |
10% Owner |
– – • |
2022-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
184,903 |
9,525 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
10% Owner |
– – • |
2022-10-25 |
4 |
S |
$0.15 |
$262,264 |
D/D |
(1,784,109) |
4,857,525 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,015,471 |
3,220 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2022-06-21 |
4 |
B |
$16.00 |
$5,000,000 |
D/D |
312,500 |
6,745,262 |
2.45 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2022-05-25 |
4 |
S |
$0.08 |
$362,720 |
I/I |
(4,445,093) |
0 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2022-05-24 |
4 |
S |
$0.07 |
$387,943 |
I/I |
(5,931,843) |
4,445,093 |
0 |
- |
|
| HOOD |
Robinhood Markets, Inc. |
Director |
– • – |
2022-05-02 |
4 |
A |
$0.00 |
$0 |
I/I |
375,098 |
36,688 |
0 |
- |
|
| HOOD |
Robinhood Markets, Inc. |
Director |
– • – |
2022-05-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(24,180,253) |
0 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2022-04-11 |
4 |
B |
$1.90 |
$4,999,998 |
I/I |
2,631,578 |
10,421,428 |
1.5 |
- |
|
| HOOD |
Robinhood Markets, Inc. |
Director |
– • – |
2022-01-31 |
4 |
S |
$14.22 |
$29,598 |
I/I |
(2,082) |
0 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
